Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

How I Treat Challenging Transfusion Cases in Sickle Cell Disease

Stella T. Chou, Jeanne E Hendrickson

Blood blood.2023023648.

https://doi.org/10.1182/blood.2023023648

Published: 2024

Journal Articles

Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression

Blood (2023) 142 (12): 1082–1098.

https://doi.org/10.1182/blood.2022018591

Published: 2023

Includes: Supplemental data

Journal Articles

Introduction to a How I Treat series on consultative hematology for inpatients

Jeanne E. Hendrickson, Thomas L. Ortel

Blood (2023) 142 (9): 751–752.

https://doi.org/10.1182/blood.2023019877

Published: 2023

Journal Articles

Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice

Ryan Jajosky, Seema R. Patel, Shang-Chuen Wu, Kashyap Patel, Mischa Covington, Mary Vallecillo-Zúniga, Diyoly Ayona, Ashley Bennett, C. John Luckey, Krystalyn E. Hudson, Jeanne E. Hendrickson, Stephanie C. Eisenbarth, Cassandra D. Josephson, Patricia E. Zerra, Sean R. Stowell, Connie M. Arthur

Blood (2023) 141 (21): 2642–2653.

https://doi.org/10.1182/blood.2022016588

Published: 2023

Journal Articles

SRSF2 or TET2 Mutations in Patients with MDS Predict Increased Red Blood Cell Alloimmunization

Juliana Guarente, Jeanne E. Hendrickson, Fangyong Li, Stephen Parziale, Christopher A. Tormey, Alexa J. Siddon

Blood (2022) 140 (Supplement 1): 5706–5707.

https://doi.org/10.1182/blood-2022-169888

Published: 2022

Journal Articles

Antibody-Mediated Antigen Loss Can Switch an Augmented Immune Response to Antibody-Mediated Immunosuppression

Ryan Philip Jajosky, Jerry W. Allen, Patricia E Zerra, Cheryl L Maier, Satheesh Chonat, Chance John Luckey, John D. Roback, Ross M. Fasano, Cassandra D. Josephson, John P Manis, Li Chai, Jeanne E. Hendrickson, Krystalyn E Hudson, Connie M. Arthur, Sean R. Stowell

Blood (2022) 140 (Supplement 1): 73–74.

https://doi.org/10.1182/blood-2022-170081

Published: 2022

Journal Articles

A US-Wide Red Blood Cell Alloantibody Exchange Can Decrease Mortality and Produce Cost Savings in the Care of Alloimmunized Patients with Sickle Cell Disease

George Goshua, Ronald G. Hauser, Chris Tormey, Ankur Pandya, Jeanne E. Hendrickson

Blood (2022) 140 (Supplement 1): 2147–2148.

https://doi.org/10.1182/blood-2022-169099

Published: 2022

Journal Articles

Marginal zone B cells mediate a CD4 T-cell–dependent extrafollicular antibody response following RBC transfusion in mice

Patricia E. Zerra, Seema R. Patel, Ryan Philip Jajosky, Connie M. Arthur, James W. McCoy, Jerry William Lynn Allen, Satheesh Chonat, Ross M. Fasano, John D. Roback, Cassandra D. Josephson, Jeanne E. Hendrickson, Sean R. Stowell

Blood (2021) 138 (8): 706–721.

https://doi.org/10.1182/blood.2020009376

Published: 2021

Includes: Supplemental data

Journal Articles

Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura

George Goshua, Pranay Sinha, Jeanne E. Hendrickson, Christopher Tormey, Pavan K. Bendapudi, Alfred Ian Lee

Blood (2021) 137 (7): 969–976.

https://doi.org/10.1182/blood.2020006052

Published: 2021

Includes: Supplemental data

Journal Articles

Type I Interferon Gene Signature in Peripheral Blood Mononuclear Cells of Sickle Cell Disease Patients and a Connection to RBC Alloimmunization

Emaan Madany, BS, June Young Lee, B.S., Jeanne E. Hendrickson, MD, David R Gibb, MDPhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142935

Published: 2020

Journal Articles

Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience

Sabrina L. Browning, MD, Michael Gormally, MD PhD, Neima Briggs, MD PhD, Muyi Li, MD, Alan Zakko, MD, Maudry Laurent-Rolle, MD PhD, Joseph Ladines-Lim, MD, Alyssa Morrison, BS, MS2, Prakash Kandel, MD, Mohammad Khan, MD, Gavin X. McLeod, MD, Gregory K. Buller, MD FACP, Kent A. Owusu, PharmD, Miriam M. Treggiari, MD PhD MPH, Jeanne E. Hendrickson, MD, Christopher A. Tormey, MD, Mahalia S. Desruisseaux, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-137352

Published: 2020

Journal Articles

Optimization of Plerixafor Utilization Based on Peripheral Blood CD34+ Count for Autologous Peripheral Blood Stem-Cell Collection

Gaurav K. Gupta, MDPhD, Sera Perreault, PharmD, Stuart Seropian, MD, Christopher A. Tormey, MD, Jeanne E. Hendrickson, MD

Blood (2020) 136 (Supplement 1): 41.

https://doi.org/10.1182/blood-2020-140171

Published: 2020

Journal Articles

Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

George Goshua, MD, Pranay Sinha, MD, Jeanne E. Hendrickson, MD, Christopher A. Tormey, MD, Pavan Bendapudi, MD, Alfred Ian Lee, MD PhD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-138515

Published: 2020

Journal Articles

COVID-19 and the Coombs test

Jeanne E. Hendrickson, Christopher A. Tormey

Blood (2020) 136 (6): 655–656.

https://doi.org/10.1182/blood.2020007483

Published: 2020

Journal Articles

Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice

Vicente Escamilla-Rivera, Jingchun Liu, David R. Gibb, Manjula Santhanakrishnan, Dong Liu, James E. Forsmo, Stephanie C. Eisenbarth, Ellen F. Foxman, Sean R. Stowell, Chance John Luckey, James C. Zimring, Krystalyn E. Hudson, Jeanne E. Hendrickson

Blood (2020) 135 (22): 1983–1993.

https://doi.org/10.1182/blood.2020005018

Published: 2020

Includes: Supplemental data

Journal Articles

Increased Expression of Type 1 Interferon Stimulated Genes in Sickle Cell Disease and a Potential Association with RBC Alloimmunization

Emaan Madany, BS, Najwa El Kadi, PhD, Sumaarg Pandya, Jeanne E. Hendrickson, MD, David R Gibb, MD PhD

Blood (2019) 134 (Supplement_1): 716.

https://doi.org/10.1182/blood-2019-124899

Published: 2019

Journal Articles

Baseline Pain in Adults with Sickle Cell Disease Can be Neuropathic or Nociceptive and Outcomes Differ between Pain Types

Susanna A Curtis, MD, Ariadna Forray, MD, Jeanne E. Hendrickson, MD, John D. Roberts, MD

Blood (2019) 134 (Supplement_1): 1028.

https://doi.org/10.1182/blood-2019-129106

Published: 2019

Journal Articles

The Presence and Persistence of Pregnancy-Associated Red Blood Cell Alloantibodies in Blood Donors

Raisa Balbuena-Merle, MD, Ronald G. Hauser, MD, Matthew Karafin, MD, Sylvia Tan, MS, Bryan R Spencer, MPH, PhD, Nareg Roubinian, MD, Yanyun Wu, MD PhD, Darrell Triulzi, MD, Steven Kleinman, MD, Jerry Gottschall, MD, Christopher A. Tormey, MD, Jeanne E. Hendrickson, MD

Blood (2019) 134 (Supplement_1): 2452.

https://doi.org/10.1182/blood-2019-121388

Published: 2019

Journal Articles

Transfusion-related red blood cell alloantibodies: induction and consequences

Christopher A. Tormey, Jeanne E. Hendrickson

Blood (2019) 133 (17): 1821–1830.

https://doi.org/10.1182/blood-2018-08-833962

Published: 2019

Journal Articles

Cost Effectiveness of Rituximab As Adjunctive Therapy in Reducing Apheresis Procedures and Hospital Length of Stay in Relapsed Thrombotic Thrombocytopenic Purpura

George Goshua, MD, Amit Gokhale, MD, Jeanne E. Hendrickson, MD, Christopher Tormey, MD, Alfred Ian Lee, MD PhD

Blood (2018) 132 (Supplement 1): 3814.

https://doi.org/10.1182/blood-2018-99-113621

Published: 2018

NARROW

How I Treat Challenging Transfusion Cases in Sickle Cell Disease

Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression

Introduction to a How I Treat series on consultative hematology for inpatients

Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice

SRSF2 or TET2 Mutations in Patients with MDS Predict Increased Red Blood Cell Alloimmunization

Antibody-Mediated Antigen Loss Can Switch an Augmented Immune Response to Antibody-Mediated Immunosuppression

A US-Wide Red Blood Cell Alloantibody Exchange Can Decrease Mortality and Produce Cost Savings in the Care of Alloimmunized Patients with Sickle Cell Disease

Marginal zone B cells mediate a CD4 T-cell–dependent extrafollicular antibody response following RBC transfusion in mice

Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura

Type I Interferon Gene Signature in Peripheral Blood Mononuclear Cells of Sickle Cell Disease Patients and a Connection to RBC Alloimmunization

Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience

Optimization of Plerixafor Utilization Based on Peripheral Blood CD34+ Count for Autologous Peripheral Blood Stem-Cell Collection

Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

COVID-19 and the Coombs test

Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice

Increased Expression of Type 1 Interferon Stimulated Genes in Sickle Cell Disease and a Potential Association with RBC Alloimmunization

Baseline Pain in Adults with Sickle Cell Disease Can be Neuropathic or Nociceptive and Outcomes Differ between Pain Types

The Presence and Persistence of Pregnancy-Associated Red Blood Cell Alloantibodies in Blood Donors

Transfusion-related red blood cell alloantibodies: induction and consequences

Cost Effectiveness of Rituximab As Adjunctive Therapy in Reducing Apheresis Procedures and Hospital Length of Stay in Relapsed Thrombotic Thrombocytopenic Purpura

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only